Skip to content

Molecular Characterization of Blastocystis Isolates From Human by Restriction Fragment Length Polymorphism (RFLP) Analysis

Molecular Characterization of Blastocystis Isolates From Human by Restriction Fragment Length Polymorphism (RFLP) Analysis in Sohag Governorate

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05580393
Enrollment
100
Registered
2022-10-14
Start date
2022-11-30
Completion date
2023-11-30
Last updated
2022-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blastocystis Infections

Keywords

Blastocystis, colorectal cancer, irritable bowel syndrome

Brief summary

Blastocystis is an anaerobic unicellular protozoal parasite infecting the gastrointestinal tract of humans and a wide range of animals. It is one of the most common enteric microorganisms with higher prevalence rates in developing than in developed countries. Feco-oral is the main route of transmission where low socioeconomic conditions, poor hygienic practices, close contact with animals, and drinking contaminated water act as major risk factors. Infection with Blastocystis was demonstrated in both symptomatic and asymptomatic people. For a long period, Blastocystis was considered a commensal organism with no pathogenic role, but recently, many studies linked it to different gastrointestinal symptoms such as nausea, diarrhea, and abdominal pain. Association with irritable bowel syndrome and colorectal cancer was also reported. This study aims to: \- Identify subtypes of human Blastocystis isolates in Sohag by using RFLP-PCR and provide additional information on the molecular epidemiology of this parasite in our locality.

Interventions

DIAGNOSTIC_TESTRFLP analysis of SSU rRNA

1. Genomic DNA will be extracted from Blastocystis-positive fecal samples using a specific DNA Stool Mini Kit according to the manufacturer's instructions and will be stored at -20°C until use. 2. PCR will be used to amplify a region of Blastocystis small subunit ribosomal RNA (SSU rRNA) gene. 3. The amplified products for the SSU rRNA gene will be digested to determine the strain subtype of Blastocystis spp. using specific restriction enzymes.

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Patients from outpatient clinics, Sohag hospitals.

Exclusion criteria

* Patients received antiparasitic drugs in the last two weeks

Design outcomes

Primary

MeasureTime frameDescription
The number of cases with subtypes of human Blastocystis isolates in Sohag14 weeks following the startpoint of the study.by using RFLP-PCR

Secondary

MeasureTime frameDescription
The number of cases with Blastocystis infection is recorded.14 weeks following the startpoint of the study.By molecular examination of stool samples from 100 patients

Contacts

Primary ContactShimaa Refaey Mohamed Abd-Elal, assistant lecturer
Shimaa.refaee@med.sohag.edu.eg01144981097

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026